Projects per year
Fingerprint
Dive into the research topics where Ahishakiye Neema Jumapili is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
FWOSB119: Optimized anti-Neuropilin-1 Nanobody formats as cancer therapy
Jumapili, A. N. & Van Ginderachter, J.
1/11/21 → 31/10/25
Project: Fundamental
-
ANI296: Neuropilin-1 blockade with optimized nanobody formats as novel cancer therapy
Van Ginderachter, J. & Jumapili, A. N.
1/01/22 → 31/12/22
Project: Fundamental
-
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity
Lebegge, E., Kancheva, D., Van Craenenbroeck, J., Ernst, S., Bardet, P. M. R., Caro, A. A., Kiss, M., Jumapili, N. A., Barthelmess, R. M., Zivalj, M., Assaf, N., Ali, L., Elkrim, Y., Demuytere, J., De Jonge, J., Raes, G., Hadadi, E., Devoogdt, N., Vincke, C., Movahedi, K., & 6 others, May 2025, In: European Journal of Immunology. 55, 5, p. 1-10 10 p., e202551804.Research output: Contribution to journal › Article › peer-review
Open Access -
Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer
De Groof, T., Lauwers, Y., Vincke, C., Van Craenenbroeck, J., Jumapili, A. N., Mora Barthelmess, R., Courtoy, G. E., Waelput, W., De Pauw, T., Raes, G., Devoogdt, N. & Van Ginderachter, J., 18 Dec 2024, In: Proceedings of the National Academy of Sciences of the United States of America. 121, 52, 12 p., e2409668121.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
A few good reasons to use nanobodies for cancer treatment: A few good reasons to use nanobodies for cancer treatment
Jumapili, N. A., Zivalj, M., Barthelmess, R. M., Raes, G., De Groof, T. W. M., Devoogdt, N., Stijlemans, B., Vincke, C. & Van Ginderachter, J. A., Sept 2023, In: European Journal of Immunology. 53, 9, p. 1-8 8 p., e2250024.Research output: Contribution to journal › Article › peer-review
Open AccessFile14 Citations (Scopus)53 Downloads (Pure) -
Anti-Neuropilin-1 Nanobodies as Novel Cancer Therapeutics
Jumapili, A. N., 2022.Research output: Unpublished contribution to conference › Poster
-
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development
Jumapili, A. N., 2022.Research output: Unpublished contribution to conference › Poster
Datasets
-
Dataset Imaging of Tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer
Lauwers, Y. (Creator), Van Ginderachter, J. (Creator), Devoogdt, N. (Creator), De Groof, T. (Creator), Vincke, C. (Creator), Van Craenenbroeck, J. (Creator), Raes, G. (Creator), De Pauw, T. (Creator), Mora Barthelmess, R. (Creator), Jumapili, A. N. (Creator), Courtoy, G. (Creator) & Waelput, W. (Creator), Zenodo, 5 Dec 2024
Dataset